"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

The global neuronavigation systems market is set for remarkable expansion, with projections estimating a market value of USD 4,794.5 million by 2032, up from USD 2,120.0 million in 2022. This surge is ...

TRILUMINATE's primary endpoint was a hierarchical composite of death from any cause or tricuspid valve surgery, ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological ...

With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that ...

STEUBENVILLE — Research suggests that exercise can be beneficial for individuals who suffer from Parkinson’s Disease, a ...

The judge vacated the FDA’s final rule, which was strongly opposed by the laboratory industry, and remanded the matter to HHS ...

Budgeted spending for NIH BRAIN Initiative has plunged by more than half, from $680 million in 2023 to $320 million this year ...

The global bariatric surgeries market is projected to reach USD 27.64 Billion by 2030, driven by the growing demand for ...

Received FDA authorization and recorded first commercial sales of ARC-EX SystemSecured strategic investment from Ottobock and extended cash ...

Updated biographies for board candidates at the upcoming Annual General Meeting ...